Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abbot, absorption, affiliated, anticoagulant, anticoagulation, apposition, attack, attrition, autoimmune, BBI, belief, bloodstream, cashflow, categorized, chain, circulatory, comfort, comparison, conduit, conventional, curve, denied, derecognize, DIARECTTM, diligence, disability, discernable, dose, dual, DVT, encounter, force, Fr, Galway, grew, highest, incorrect, infrapopliteal, infusion, inquired, interrelated, interventionalist, intuitive, kind, kinking, leader, learning, led, lifecycle, longest, longevity, loop, loose, mathematical, MDD, MDR, mm, modest, module, national, navigate, navigating, partnership, PE, PounceTM, preserve, pressure, prevail, priority, profile, prove, provisional, purpose, reevaluate, refinancing, relinquishment, repayment, resistance, restructuring, resurgence, ReVene, ReVeneTM, robust, RX, satisfactory, screw, segregated, session, setup, simply, smaller, spasm, spring, staffing, steady, strict, superb, superior, tension, thigh, thrombolytic, track, trackability, transfemoral, transportation, transradial, treatable, turn, unforeseen, unsuccessful, vessel, Vetex, vital, walk, wall, withholding, write
Removed:
acceleration, accomplishment, advertise, annualized, arm, attractive, biodurable, biomaterial, blended, bolstered, buildup, BV, calculate, call, cardiology, clause, clean, combining, concert, conjunction, convergence, coordinate, coupled, demonstrate, dilation, earlier, embolism, entirety, exert, exhibit, exit, extreme, fistula, foresee, Greaney, headcount, hedged, IDE, implantable, influence, InnoCore, input, instrument, insulin, islet, lab, leaving, limitation, linked, literature, living, marked, marketable, measuring, med, neurology, nonfinancial, nonperformance, obesity, offsetting, ophthalmology, orderly, origination, overpaid, overpayment, partially, participating, population, prevalence, publish, pulmonary, pursuit, rata, reclassified, recognizing, redefined, resolving, rest, revaluation, secondary, significance, sophisticated, stemming, stent, strain, suggest, TCJA, tech, tenure, threshold, transact, transformed, troubleshooting, unaudited, uncollectible, validate, valuable, worked, world
Filing tables
Filing exhibits
- 10-K Annual report
- 10.27 EX-10.27 Surmodics, Inc. Board Compensation Policy, Amended and Restated As of September 23, 2021.
- 21 EX-21 Subsidiaries of the Registrant
- 23 EX-23 Consent of Deloitte & Touche LLP
- 31.1 EX-31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 EX-31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 EX-32.1 Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 EX-32.2 Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated SRDX transcripts
SRDX similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-104258, 333-123521, 333-165098, 333-165101, 333-54266, 333-231199 and 333-251486 on Form S-8 and Registration Statement No. 333-238611 on Form S-3 of our reports dated November 24, 2021, relating to the consolidated financial statements and financial statement schedule of Surmodics, Inc. and subsidiaries and the effectiveness of Surmodics, Inc.’s and subsidiaries internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended September 30, 2021.
/s/ DELOITTE & TOUCHE LLP
Minneapolis, Minnesota
November 24, 2021